Publication |
Data |
|
Phenotype
|
Helal et al., 2021
|
Figure 1
|
|
|
|
Figure 2
|
|
|
|
Figure 3
|
|
|
|
Figure 4
|
|
- cholangiocyte zn-8 labeling increased amount, abnormal
- liver bile acid biosynthetic process increased process quality, abnormal
- liver bile acid biosynthetic process normal process quality, normal
- liver EGFP expression increased amount, abnormal
- liver increased size, abnormal
- liver normal size, normal
- liver proliferative region ab5-pcna labeling increased amount, abnormal
- liver triglyceride-rich plasma lipoprotein particle increased amount, abnormal
- liver triglyceride-rich plasma lipoprotein particle increased amount, exacerbated
- whole organism s1pr2 expression increased amount, abnormal
|
|
Figure 5
|
|
|
|
Figure 6
|
|
|